A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients-Reference-Cited by-同舟云学术

A comparative analysis of tioguanine versus low-dose thiopurines combined with allopurinol in inflammatory bowel disease patients

Published:2020-04-27 Issue:11 Volume:51 Page:1076-1086
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Biemans Vince B. C.¹²^ORCID,Savelkoul Edo¹,Gabriëls Ruben Y.³,Simsek Melek⁴⁵,Dijkstra Gerard³⁶,Pierik Marieke J.²,West Rachel L.⁷,de Boer Nanne K.H.⁴⁵,Hoentjen Frank¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Radboud University Medical Centre; Nijmegen The Netherlands

2. Department of Gastroenterology and Hepatology; Maastricht University Medical Centre; Maastricht The Netherlands

3. University Medical Centre Groningen; Groningen The Netherlands

4. Amsterdam University Medical Centre; Vrije Universiteit; Amsterdam The Netherlands

5. Amsterdam Gastroenterology & Metabolism research institute; Amsterdam The Netherlands

6. University of Groningen; Groningen the Netherlands

7. Franciscus Gasthuis & Vlietland; Rotterdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15730/fullpdf

Reference35 articles.

1. Improvements in the long-term outcome of Crohn's disease over the past two decades and the relation to changes in medical management: results from the population-based IBDSL cohort;Jeuring;Am J Gastroenterol,2017

2. Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience;Macaluso;Scand J Gastroenterol,2017

3. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis;Osterman;Gastroenterology,2006

4. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease;Dubinsky;Gastroenterology,2000

5. The pharmacogenetic basis of individual variation in thiopurine metabolism;Blaker;Per Med,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-02-24

2. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study;Therapeutic Advances in Gastroenterology;2024-01

3. Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study);Alimentary Pharmacology & Therapeutics;2023-12-14

4. Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency;Metabolites;2023-10-06

5. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients;Inflammatory Bowel Diseases;2023-09-02